4//SEC Filing
Heerma Peter 4
Accession 0001789617-25-000006
CIK 0001438533other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:45 PM ET
Size
5.1 KB
Accession
0001789617-25-000006
Insider Transaction Report
Form 4
Heerma Peter
CHIEF COMMERCIAL OFFICER
Transactions
- Sale
Common Stock
2025-10-28$30.00/sh−2,662$79,860→ 124,662 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001789617
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:45 PM ET
- Size
- 5.1 KB